Stock Analysis | New York Mellon Outlook - Cautious Optimism Amid Mixed Fundamentals

Market Snapshot

Takeaway: New York Mellon (BK) is showing a 3.79% price rise, supported by strong technical indicators and cautious optimism from the market. However, fundamental factors remain a concern, scoring below 5 on our internal diagnostic scale.

News Highlights

Currently, there are no recent news items for New York Mellon. Investors should remain tuned to potential updates that could affect the stock’s direction, especially with the technical indicators suggesting a volatile market.

Analyst Views & Fundamentals

New York Mellon has one active analyst, David Smith from Truist Securities, who has a strong historical win rate of 85.7%. The simple average rating is 3.00, while the weighted rating is 5.35, suggesting that recent expectations align with the current price rise. Despite this, the ratings are inconsistent, indicating differing views among analysts.

• Revenue-MV: Value is -0.2763; internal diagnostic score: 3.00
• Operating cycle: Value is 336.32; internal diagnostic score: 2.00
• Days sales outstanding: Value is 119.07; internal diagnostic score: 2.00
• Non-current assets / Total assets (%): Value is 53.08%; internal diagnostic score: 0.00
• Cash-UP: Value is 1.69; internal diagnostic score: 1.00
• Interest coverage ratio (EBIT / Interest expense) (%): Value is -89.63%; internal diagnostic score: 2.00
• Operating revenue (YoY growth rate %): Value is 422.22%; internal diagnostic score: 2.00
• Current assets / Total assets (%): Value is 47.29%; internal diagnostic score: 0.00
• Current ratio: Value is 19.02; internal diagnostic score: 2.00
• Cash-MV: Value is 0.4380; internal diagnostic score: 1.00

Money-Flow Trends

Recent money-flow patterns for New York Mellon show a negative overall trend, with inflow ratios across all categories hovering around the 48% mark. Specifically, block inflow ratio is 47.89%, indicating that large institutional investors are cautious. The negative flow may suggest profit-taking or a lack of strong conviction despite the positive price movement.

Key Technical Signals

New York Mellon’s technical side is showing strong and cautious optimism according to our internal diagnostic score of 7.06. Here are the key signals:

• WR Overbought: internal diagnostic score: 6.88, with 93 historical signals and a 60.22% win rate.
• RSI Overbought: internal diagnostic score: 6.63, with 43 signals and a 58.14% win rate.
• MACD Golden Cross: internal diagnostic score: 7.68, a strong bullish signal with a 75.00% win rate and 8 historical signals.

Recent Chart Patterns: A significant MACD Golden Cross occurred on August 28, followed by WR and RSI Overbought signals on the same day. This suggests a potential short-term momentum boost.

Key Insight: The technical indicators show that the market is in a volatile state, with bullish signals dominating (1 bullish vs. 0 bearish).

Conclusion

New York Mellon is showing a mix of caution and optimism across both technical and market analyses. While the MACD Golden Cross and WR/RSI Overbought signals suggest a positive near-term outlook, fundamentals remain a concern with several key factors scoring poorly. Investors may consider waiting for a pull-back to re-enter, especially as money flows remain cautious despite price strength. Keep an eye on upcoming fundamentals and analyst updates for further direction.